A novel biomarker panel index improves risk stratification after ischemic stroke

Area of Science:

• Biomarker discovery
• Stroke research
• Clinical diagnostics

Background:

• Investigated 92 blood biomarkers related to ischemic injury, inflammation, hemostasis, and vascular resistance.
• Focused on predicting post-stroke mortality and identifying stroke etiology.

Purpose of the Study:

• To develop a novel Biomarker Panel Index (BPI) for improved risk stratification after ischemic stroke.
• To assess the BPI's association with mortality and cardioembolic stroke etiology.

Main Methods:

• Prospective study of 320 stroke patients measuring 92 biomarkers.
• Logistic regression used to identify 16 significant biomarkers for BPI creation.
• Regression models fitted to evaluate BPI's association and discriminatory accuracy for mortality and stroke etiology.

Main Results:

• The BPI independently predicted mortality (OR 1.68) and cardioembolic stroke etiology (OR 1.38) after adjusting for covariates.
• The BPI significantly improved prediction accuracy for mortality (AUC 0.93) and cardioembolic stroke (AUC 0.70) compared to clinical models.
• The BPI demonstrated superior discriminatory accuracy over established prediction models.

Conclusions:

• A novel Biomarker Panel Index (BPI) enhances risk stratification for post-ischemic stroke mortality.
• The BPI is independently associated with mortality and cardioembolic stroke etiology.
• External validation of the BPI is recommended for broader clinical application.